Wordt geladen...
Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc‐concentration modelling
AIM: The aim of this study was to characterize the effect of inotuzumab ozogamicin on QT interval in patients with B‐cell malignancies. METHODS: Data were pooled from three clinical studies including 250 patients (n = 2743) who received inotuzumab ozogamicin monotherapy. Patients with relapsed/refra...
Bewaard in:
| Gepubliceerd in: | Br J Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379221/ https://ncbi.nlm.nih.gov/pubmed/30536405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13832 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|